应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRK 默沙东
未开盘 04-21 16:00:00 EDT
77.85
-0.15
-0.19%
盘后
78.00
+0.15
+0.19%
19:59 EDT
最高
78.19
最低
76.99
成交量
1,101万
今开
78.08
昨收
78.00
日振幅
1.54%
总市值
1,959亿
流通市值
1,956亿
总股本
25.16亿
成交额
8.54亿
换手率
0.44%
流通股本
25.12亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
吉利德科学(GILD.O)宣布Trodelvy(戈沙妥珠单抗)联合Keytruda(帕博利珠单抗)在第三级临床试验中达到
美港电讯 · 04-21 12:34
吉利德科学(GILD.O)宣布Trodelvy(戈沙妥珠单抗)联合Keytruda(帕博利珠单抗)在第三级临床试验中达到
以创新形式集结参与力量,共同开拓健康守护新赛道
上观新闻 · 04-21 04:23
以创新形式集结参与力量,共同开拓健康守护新赛道
近90%患者缓解的强生口服多肽疗法;默沙东达近5亿美元口服多肽疗法合作 TIDES周报
动脉网 · 04-18
近90%患者缓解的强生口服多肽疗法;默沙东达近5亿美元口服多肽疗法合作 TIDES周报
第 12 项!默沙东启动科伦博泰 TROP2 ADC III 期临床试验
Insight数据库 · 04-18
第 12 项!默沙东启动科伦博泰 TROP2 ADC III 期临床试验
蒙特利尔银行下调默克公司、辉瑞目标价
金吾财讯 · 04-17
蒙特利尔银行下调默克公司、辉瑞目标价
默沙东九价HPV疫苗在华获批男性适应证 适用于16至26岁男性接种
每日经济新闻 · 04-14
默沙东九价HPV疫苗在华获批男性适应证 适用于16至26岁男性接种
默沙东九价人乳头瘤病毒疫苗(酿酒酵母)在华获批上市男性适应证
美港电讯 · 04-14
默沙东九价人乳头瘤病毒疫苗(酿酒酵母)在华获批上市男性适应证
港股异动 | 科伦博泰生物-B(06990)涨超6% 核心产品sac-TMT顺利获批上市 默沙东快速推进全球3期临床
智通财经 · 04-14
港股异动 | 科伦博泰生物-B(06990)涨超6% 核心产品sac-TMT顺利获批上市 默沙东快速推进全球3期临床
近80亿β受体阻滞剂市场:阿斯利康、齐鲁、默克三强争霸
动脉网 · 04-14
近80亿β受体阻滞剂市场:阿斯利康、齐鲁、默克三强争霸
默沙东架构调整!成熟产品进集采后,MNC借力创新运营模式
医药经济报 · 03-11
默沙东架构调整!成熟产品进集采后,MNC借力创新运营模式
凌激赴北京市开展“服务保障进外企”专项走访活动并主持召开北京地区外资企业圆桌会
美港电讯 · 03-08
凌激赴北京市开展“服务保障进外企”专项走访活动并主持召开北京地区外资企业圆桌会
由“仿”到“创” 中国医药迈步康庄大道
中国新闻网 · 03-08
由“仿”到“创” 中国医药迈步康庄大道
媒体点赞机构买入,“走红”抗癌药来自“广州制造”
广州日报 · 03-07
媒体点赞机构买入,“走红”抗癌药来自“广州制造”
国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了
第一财经 · 03-07
国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了
金十数据整理:每日美股市场要闻速递(3月6日 周四)
美港电讯 · 03-06
金十数据整理:每日美股市场要闻速递(3月6日 周四)
首个肿瘤疫苗有望在2027年推出,用于治疗这种癌症
第一财经 · 03-06
首个肿瘤疫苗有望在2027年推出,用于治疗这种癌症
首个肿瘤疫苗有望在2027年推出 用于治疗皮肤癌
金十财经 · 03-06
首个肿瘤疫苗有望在2027年推出 用于治疗皮肤癌
【Moderna预计2027年推出与默沙东共同开发的皮肤癌症疫苗】Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。
金融界 · 03-06
【Moderna预计2027年推出与默沙东共同开发的皮肤癌症疫苗】Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。
Moderna(MRNA.US)携手默沙东(MRK.US)冲刺2027 一款重磅皮肤癌疫苗进入倒计时
智通财经 · 03-06
Moderna(MRNA.US)携手默沙东(MRK.US)冲刺2027 一款重磅皮肤癌疫苗进入倒计时
传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战
智通财经 · 03-05
传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战
加载更多
公司概况
公司名称:
默沙东
所属市场:
NYSE
上市日期:
--
主营业务:
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。
发行价格:
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":77.85,"timestamp":1745265600000,"preClose":78,"halted":0,"volume":11009959,"hourTrading":{"tag":"盘后","latestPrice":78,"preClose":77.85,"latestTime":"19:59 EDT","volume":1282465,"amount":99840412.9986,"timestamp":1745279970591},"delay":0,"floatShares":2512390293,"shares":2516394128,"eps":6.74,"marketStatus":"未开盘","change":-0.15,"latestTime":"04-21 16:00:00 EDT","open":78.08,"high":78.19,"low":76.99,"amount":854161867.58556,"amplitude":0.015385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.74,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":78,"dividendRate":0.039563,"preHourTrading":{"tag":"盘前","latestPrice":78,"preClose":78,"latestTime":"09:29 EDT","volume":2840,"amount":220668.994,"timestamp":1745242170201},"postHourTrading":{"tag":"盘后","latestPrice":78,"preClose":77.85,"latestTime":"19:59 EDT","volume":1282465,"amount":99840412.9986,"timestamp":1745279970591},"volumeRatio":0.640103,"optionData":{"bulkOrders":[{"symbol":"MRK","call":true,"expireDate":1799989200000,"strike":"120.0","timestamp":1745248877559,"price":2.08,"volume":1100,"amount":228800,"type":"-"}]},"impliedVol":0.4546,"impliedVolPercentile":0.964},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2529760805","title":"吉利德科学(GILD.O)宣布Trodelvy(戈沙妥珠单抗)联合Keytruda(帕博利珠单抗)在第三级临床试验中达到","url":"https://stock-news.laohu8.com/highlight/detail?id=2529760805","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529760805?lang=zh_cn&edition=full","pubTime":"2025-04-21 20:34","pubTimestamp":1745238866,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BJT1NW94.SGD","03347","LU1934455194.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU1989772923.USD","LU1917777945.USD","BK4585","LU1989771016.USD","LU1116320737.USD","MRK","LU0320765646.SGD","LU1066051811.HKD","LU1116320901.HKD","SG9999014542.SGD","LU1162221912.USD","BK4588","LU1571399168.USD","LU0965508806.USD","LU2361045086.USD","LU1093756168.USD","BK4568","LU1430594728.SGD","LU1585245621.USD","SG9999015341.SGD","LU0203345920.USD","BK4533","SG9999014567.USD","IE00BBT3K403.USD","BK4559","LU1291159041.SGD","GILD","BK1583","LU0238689110.USD","LU2106854487.HKD","IE0009355771.USD","LU0211331839.USD","LU1066051498.USD","SG9999002224.SGD","LU0965509101.SGD","BK4532","LU0965509283.SGD","LU2361044949.HKD","LU0070302665.USD","LU2461242641.AUD","SG9999015358.SGD","LU1069347547.HKD","LU2361044865.SGD","SGXZ57979304.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2529845382","title":"以创新形式集结参与力量,共同开拓健康守护新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2529845382","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529845382?lang=zh_cn&edition=full","pubTime":"2025-04-21 12:23","pubTimestamp":1745209380,"startTime":"0","endTime":"0","summary":"由新华网发起、默沙东支持的“畅跑马拉松,防护你我他”——“HPV男女共防计划”北半马主题活动新闻发布会日前举行。默沙东与多方携手,以创新形式集结大众的参与力量,共同开拓健康守护新赛道,以期未来在全国范围内提升“男女共防HPV相关癌症及疾病”的科普认知,呼吁社会各界加强HPV感染男女共防的健康意识,助力共建HPV感染预防新生态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213382735722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU1699723380.USD","LU0208291251.USD","SG9999013999.USD","LU1934455194.USD","LU2089984988.USD","IE00BLSP4239.USD","LU0234572021.USD","LU2361045086.USD","LU0320765489.SGD","LU0266013472.USD","LU1116320737.USD","SGXZ57979304.SGD","LU0238689110.USD","BK4516","LU1929549753.HKD","LU0265550359.USD","LU1983299246.USD","LU2023250504.SGD","IE00B2B36J28.USD","LU2023250843.SGD","MRK","LU2361044949.HKD","LU0203345920.USD","IE00BN8TJ469.HKD","LU1066051811.HKD","LU1093756168.USD","LU1162221912.USD","LU1066051498.USD","LU1989771016.USD","IE0002141913.USD","SG9999002224.SGD","LU1023059063.AUD","SG9999001176.USD","LU1941712264.USD","LU2112291526.USD","SG9999014567.USD","LU0006306889.USD","LU1917777945.USD","IE00B1BXHZ80.USD","LU1934455277.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1093756325.SGD","LU1934455863.HKD","LU1430594728.SGD","IE0009355771.USD","SG9999014559.SGD","LU0106261372.USD"],"gpt_icon":0},{"id":"2528479470","title":"近90%患者缓解的强生口服多肽疗法;默沙东达近5亿美元口服多肽疗法合作 TIDES周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2528479470","media":"动脉网","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528479470?lang=zh_cn&edition=full","pubTime":"2025-04-19 07:41","pubTimestamp":1745019660,"startTime":"0","endTime":"0","summary":"强生口服多肽疗法3期临床试验结果积极,近90%的青少年患者皮肤症状清除。默沙东与Cyprumed合作开发口服多肽药物。TIDES疗法领域迎来系列进展,包括其他多肽疗法的临床试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419093620973d2c02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419093620973d2c02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1732799900.SGD","LU1066051225.USD","IE00B1BXHZ80.USD","LU1023059063.AUD","IE00BVYPNV92.GBP","LU0058720904.USD","SG9999002224.SGD","LU0238689110.USD","LU0320765646.SGD","SG9999002232.USD","SG9999014542.SGD","JNJ","BK4534","IE00BFTCPJ56.SGD","LU1894683348.USD","LU2129689605.HKD","LU1267930813.SGD","IE00B19Z3B42.SGD","IE0002141913.USD","LU1291159041.SGD","LU0640476718.USD","SG9999014575.USD","LU0203345920.USD","LU1066051498.USD","MRK","IE00BLSP4452.SGD","LU0208291251.USD","LU2129689431.USD","IE00B2B36J28.USD","LU2129689514.USD","LU0792757196.USD","BK4532","IE00BVYPNW00.USD","LU2430703251.USD","LU1430594728.SGD","LU0795875086.SGD","LU1585245621.USD","LU0795875169.SGD","LU1221951129.SGD","LU0006306889.USD","LU1934455863.HKD","BK4568","IE00BN8TJ469.HKD","LU1196500208.SGD","LU1244550494.USD","LU0345769631.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU0203347892.USD","LU1035773651.USD"],"gpt_icon":0},{"id":"2528595000","title":"第 12 项!默沙东启动科伦博泰 TROP2 ADC III 期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2528595000","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528595000?lang=zh_cn&edition=full","pubTime":"2025-04-18 17:23","pubTimestamp":1744968229,"startTime":"0","endTime":"0","summary":"4 月 18 日,中国药物临床试验登记与信息公示平台显示,默沙东登记了一项比较 Sac-TMT联合/不联合帕博利珠单抗与 TPC一线治疗不可切除/转移性三阴性乳腺癌的 III 期研究。Insight 数据库显示,这是默沙东针对该药启动的第 12 项全球多中心临床试验。该药首次于 2024 年 11 月获 NMPA 批准上市,用于三阴性乳腺癌的二线治疗。2022 年 5 月,科伦博泰与默沙东签署合作协议,授予后者在大中华区以外的所有地区开发、使用、制造及商业化Sac-TMT 的独家权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418172807a6bf22a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418172807a6bf22a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0006306889.USD","SG9999014559.SGD","LU1929549753.HKD","ADC","IE00BJJMRZ35.SGD","LU1116320737.USD","LU1983299246.USD","SGXZ57979304.SGD","LU0320765489.SGD","LU1116320901.HKD","LU0266013472.USD","LU1057294990.SGD","BK4559","BK4534","LU1037948897.HKD","LU0058720904.USD","BK4134","LU1699723380.USD","IE0009355771.USD","III","LU0985320562.USD","LU0289739699.SGD","SG9999013999.USD","LU1989771016.USD","SG9999015341.SGD","LU0965509101.SGD","LU1941712348.USD","LU1989772840.SGD","LU1430594728.SGD","BK4588","BK4585","LU0965509010.AUD","MRK","LU2324357040.USD","IE0002141913.USD","BK4533","IE00BFTCPJ56.SGD","SG9999014567.USD","SG9999001176.SGD","LU1974910355.USD","SG9999014542.SGD","LU0965509283.SGD","LU1066053197.SGD","LU1066051498.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","SG9999015358.SGD","LU0965508806.USD","BK4550","BK4080"],"gpt_icon":0},{"id":"2528971590","title":"蒙特利尔银行下调默克公司、辉瑞目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2528971590","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528971590?lang=zh_cn&edition=full","pubTime":"2025-04-17 19:31","pubTimestamp":1744889485,"startTime":"0","endTime":"0","summary":"金吾财讯 | 蒙特利尔银行将默克公司目标股价从96美元下调至89美元,将辉瑞目标价从36美元下调至30美元。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","BMO","PFE"],"gpt_icon":0},{"id":"2527799970","title":"默沙东九价HPV疫苗在华获批男性适应证 适用于16至26岁男性接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2527799970","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527799970?lang=zh_cn&edition=full","pubTime":"2025-04-14 15:07","pubTimestamp":1744614450,"startTime":"0","endTime":"0","summary":"4月14日,默沙东宣布,佳达修9(以下简称“九价HPV疫苗”)多项新适应证已获得国家药品监督管理局的上市批准,适用于16至26岁男性接种。这一获批使佳达修9成为中国境内首个且目前唯一获批、可适用于适龄男性女性接种的九价HPV疫苗。这也是继今年1月默沙东四价HPV疫苗获批用于男性接种后,默沙东在九价HPV疫苗男性适应证方面的突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504143376018174.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504143376018174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0320765646.SGD","LU0965509101.SGD","LU2361044865.SGD","LU2461242641.AUD","MRK","BK4550","LU1989771016.USD","LU0070302665.USD","LU1069347547.HKD","LU1934455277.USD","LU0058720904.USD","IE00BJT1NW94.SGD","SG9999015341.SGD","BK4559","LU0266013472.USD","LU2023250504.SGD","LU1057294990.SGD","LU1291159041.SGD","SG9999014567.USD","IE00B2B36J28.USD","SG9999015358.SGD","SG9999014559.SGD","IE00BN8TJ469.HKD","BK4585","LU0265550946.USD","IE0002141913.USD","LU1093756168.USD","SG9999001176.SGD","IE00BSNM7G36.USD","LU1941712264.USD","LU1037948541.HKD","SG9999001176.USD","LU0106261372.USD","LU0965509283.SGD","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD","LU2361044949.HKD","LU1934455863.HKD","BK4588","IE00B4R5TH58.HKD","LU0985320562.USD","LU1585245621.USD","IE0009355771.USD","LU0122379950.USD","LU1941712348.USD","LU0238689110.USD","LU1066051498.USD","LU2468319806.SGD","LU0965509010.AUD","LU0211331839.USD"],"gpt_icon":0},{"id":"2527971311","title":"默沙东九价人乳头瘤病毒疫苗(酿酒酵母)在华获批上市男性适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2527971311","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527971311?lang=zh_cn&edition=full","pubTime":"2025-04-14 14:19","pubTimestamp":1744611584,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4534","LU1974910355.USD","LU1291159041.SGD","LU1093756325.SGD","LU1116320901.HKD","IE00BSNM7G36.USD","LU1941712348.USD","LU2461242641.AUD","LU1162221912.USD","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","SGXZ57979304.SGD","LU1093756168.USD","LU1934455277.USD","SG9999002224.SGD","LU0058720904.USD","LU0238689110.USD","LU0203347892.USD","SG9999015341.SGD","LU0106261372.USD","LU0208291251.USD","SG9999015358.SGD","LU0965509283.SGD","LU1066053197.SGD","SG9999001176.SGD","LU1066051225.USD","LU1989772923.USD","MRK","LU1699723380.USD","LU1035773651.USD","LU1069347547.HKD","LU0266013472.USD","LU1430594728.SGD","LU0289739699.SGD","LU0320765646.SGD","LU1934455863.HKD","SG9999014542.SGD","LU2361044949.HKD","IE00BBT3K403.USD","IE000M9KFDE8.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","159646","LU2023250843.SGD","BK4516","LU1116320737.USD","LU0203345920.USD","LU2361044865.SGD","SG9999002232.USD","BK4588"],"gpt_icon":0},{"id":"2527942747","title":"港股异动 | 科伦博泰生物-B(06990)涨超6% 核心产品sac-TMT顺利获批上市 默沙东快速推进全球3期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2527942747","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527942747?lang=zh_cn&edition=full","pubTime":"2025-04-14 10:31","pubTimestamp":1744597910,"startTime":"0","endTime":"0","summary":"国信证券发布研报称,科伦博泰生物-B的核心产品sac-TMT/SKB264的第一和第二个适应症分别在24年底和25年初获批上市,成为首个获批肺癌适应症的TROP2 ADC。EGFRm NSCLC 2L适应症的上市申请已经获得受理,预计将在今年获批上市,EGFRm NSCLC 1L、驱动基因阴性NSCLC 1L、TNBC1L等适应症正在进行3期临床。合作伙伴默沙东已经开启了12项sac-TMT的全球多中心3期临床,涵盖了肺癌、乳腺癌、妇科肿瘤等多适应症。随着sac-TMT、塔戈利单抗和西妥昔单抗N01相继获批上市,公司正式进入商业化阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU1023059063.AUD","LU1291159041.SGD","LU1093756325.SGD","SG9999001440.SGD","LU1037948897.HKD","BK1161","LU1162221912.USD","IE00B1BXHZ80.USD","LU1093756168.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU1934455277.USD","LU2324357040.USD","LU0122379950.USD","LU0985320562.USD","BK4533","SG9999014575.USD","LU0070302665.USD","LU1037948541.HKD","LU1066053197.SGD","SG9999015358.SGD","MRK","BK4007","LU1917777945.USD","LU1571399168.USD","SG9999014567.USD","LU0265550359.USD","LU0006306889.USD","06990","LU0289739699.SGD","LU0320765489.SGD","LU2361044949.HKD","SG9999013999.USD","LU1989772840.SGD","IE00BBT3K403.USD","LU2106854487.HKD","IE000M9KFDE8.USD","LU1983299246.USD","IE0002141913.USD","LU0965509010.AUD","IE00BFTCPJ56.SGD","BK4516","BK4550","LU2023250843.SGD","LU0196878994.USD","LU1116320737.USD","SG9999002232.USD","LU2361044865.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2527442219","title":"近80亿β受体阻滞剂市场:阿斯利康、齐鲁、默克三强争霸","url":"https://stock-news.laohu8.com/highlight/detail?id=2527442219","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527442219?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:27","pubTimestamp":1744594020,"startTime":"0","endTime":"0","summary":"β受体阻滞剂市场规模近80亿,阿斯利康、齐鲁、默克三强争霸,受集采影响2023年市场规模下滑,第二代广泛应用,第三代崭露头角。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041410105894d47f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041410105894d47f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965508806.USD","LU2089984988.USD","LU1069347547.HKD","IE00BBT3K403.USD","LU1989772923.USD","LU1035773651.USD","SG9999001440.SGD","LU1430594728.SGD","LU1934455277.USD","LU0006306889.USD","LU0265550946.USD","LU2417539215.USD","LU0265550359.USD","BK4568","LU1057294990.SGD","LU1829250122.USD","LU1066051811.HKD","LU1291159041.SGD","LU1974910355.USD","LU1989771016.USD","IE0009355771.USD","MRK","LU1934455863.HKD","LU1571399168.USD","LU0889565916.HKD","LU1585245621.USD","LU1699723380.USD","LU0266013472.USD","LU0965509010.AUD","LU2023250843.SGD","SG9999002224.SGD","AZN","BK4007","BK4559","LU1037948541.HKD","LU0106261372.USD","SG9999014567.USD","IE000M9KFDE8.USD","LU2112291526.USD","BK4588","LU1093756168.USD","LU0109394709.USD","LU1989772840.SGD","IE00BLSP4239.USD","SG9999001176.USD","LU2106854487.HKD","LU0058720904.USD","LU2468319806.SGD","LU1934455194.USD","LU1929549753.HKD"],"gpt_icon":0},{"id":"2518955753","title":"默沙东架构调整!成熟产品进集采后,MNC借力创新运营模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2518955753","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518955753?lang=zh_cn&edition=full","pubTime":"2025-03-11 11:07","pubTimestamp":1741662449,"startTime":"0","endTime":"0","summary":"默沙东中国近日向员工公布了组织架构的最新调整。此次新设的企业家事业部便是默沙东创新业务运营模式的正式落地。据悉,这一事业部由默沙东中国原糖尿病事业部负责人史家维负责,将采用独特的企业家模式进行运营,整合肿瘤、院内专科医疗和糖尿病领域的成熟产品,成为极具凝聚力的整体。在业内看来,此次默沙东中国的组织架构调整,是其面对集采政策和市场变化做出的重要战略决策,但实际运营效果如何,还有待观察。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111112519640e49c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111112519640e49c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","IE000M9KFDE8.USD","LU1917777945.USD","BK4533","SG9999014559.SGD","LU0265550946.USD","IE0002141913.USD","LU1162221912.USD","LU1066051498.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU1093756325.SGD","BK4007","LU1057294990.SGD","LU0985320562.USD","LU1585245621.USD","LU1941712348.USD","MRK","LU0070302665.USD","LU0965508806.USD","LU1066051225.USD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1989772923.USD","BK4585","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU0203345920.USD","LU0211331839.USD","LU0965509010.AUD","BK4534","IE00B1BXHZ80.USD","LU0965509101.SGD","IE00BLSP4239.USD","BK4516","LU2361044949.HKD","SG9999015358.SGD","LU0106261372.USD","LU0234572021.USD","LU0289739699.SGD","LU1934455277.USD","SGXZ57979304.SGD","BK4559","LU0861579265.USD","LU1035773651.USD","LU1116320901.HKD","LU1037948541.HKD","IE00BSNM7G36.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2517844328","title":"凌激赴北京市开展“服务保障进外企”专项走访活动并主持召开北京地区外资企业圆桌会","url":"https://stock-news.laohu8.com/highlight/detail?id=2517844328","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517844328?lang=zh_cn&edition=full","pubTime":"2025-03-08 19:30","pubTimestamp":1741433415,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MRK","LU0192582467.USD","LU0314104364.USD","IE00B19Z8X17.USD","LU0345768153.USD","LU1699723380.USD","LU1868836914.USD","LU1868836591.USD","BK4504","LU1127390331.HKD","LU1974910355.USD","0O59.UK","LU0820561909.HKD","LU1929549753.HKD","LU1267930730.SGD","SG9999002232.USD","LU0861579265.USD","LU2360032135.SGD","LU1983299246.USD","SONY","LU1852331112.SGD","LU1093756168.USD","LU1988902786.USD","LU1989764664.SGD","LU2756315318.SGD","LU0950375773.USD","LU2065171311.SGD","LU0096364046.USD","D05.SI","LU0823397285.USD","IE00BKPKM429.USD","LU0235996351.USD","IE0009356076.USD","LU0417517546.SGD","SG9999015358.SGD","LU0689472784.USD","LU2361044949.HKD","LU1629891620.HKD","SBUX","IE000W1ABFV2.USD","LU2089984988.USD","SGXZ43160589.SGD","SGXZ51526630.SGD","USAW.SI","LU2471134879.HKD","LU0326948709.USD","LU2106854487.HKD","LU0873338254.USD","LU0084288322.USD","AMZN"],"gpt_icon":0},{"id":"2517443140","title":"由“仿”到“创” 中国医药迈步康庄大道","url":"https://stock-news.laohu8.com/highlight/detail?id=2517443140","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517443140?lang=zh_cn&edition=full","pubTime":"2025-03-08 19:14","pubTimestamp":1741432448,"startTime":"0","endTime":"0","summary":"【由“仿”到“创” 中国医药迈步康庄大道】“最近,一家名不见经传的中国企业生产的新药击败了全世界最畅销的抗癌药。”全国政协委员、中国医学科学院肿瘤医院主任医师赵宏在全国政协十四届三次会议首场“委员通道”上分享了一则令人振奋的消息。记者了解到,创造这一成绩的中国药企是康方生物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503083340394015.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503083340394015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU0965509010.AUD","LU1066051498.USD","09926","IE00B5MMRT66.SGD","LU1989771016.USD","SG9999014567.USD","LU1934455194.USD","SG9999001176.SGD","LU1057294990.SGD","SG9999014575.USD","LU1162221912.USD","06978","LU0070302665.USD","LU0985320562.USD","LU1571399168.USD","LU1066051225.USD","LU1066053197.SGD","LU1974910355.USD","LU0320765646.SGD","SG9999001176.USD","LU0965509283.SGD","LU1934455277.USD","LU0238689110.USD","SG9999013999.USD","LU0208291251.USD","LU1066051811.HKD","LU1794554557.SGD","IE00B4R5TH58.HKD","BK4007","LU2361045086.USD","IE00B543WZ88.USD","LU0203345920.USD","LU0122379950.USD","LU1989772840.SGD","BK4516","IE00B2B36J28.USD","MRK","LU1035773651.USD","IE00BSNM7G36.USD","LU1720050803.USD","SG9999014559.SGD","LU0265550359.USD","LU1116320737.USD","LU2361044949.HKD","SGXZ57979304.SGD","LU2106854487.HKD","BK1161"],"gpt_icon":0},{"id":"2517809494","title":"媒体点赞机构买入,“走红”抗癌药来自“广州制造”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517809494","media":"广州日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517809494?lang=zh_cn&edition=full","pubTime":"2025-03-07 20:55","pubTimestamp":1741352152,"startTime":"0","endTime":"0","summary":"近期一款“名不见经传”的抗癌药走红。广州日报新花城记者采访获悉:这款药物来自“广州制造”——广州康方药业生产的依沃西是全球首创双特异性抗体新药(商品名“依达方?”),不但可以消灭肿瘤,还能抑制肿瘤血管生长,抑制肿瘤扩散。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503073339990630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1989772923.USD","SG9999001176.USD","IE00B5MMRT66.SGD","IE00BBT3K403.USD","LU2361045086.USD","LU0238689110.USD","LU0289739699.SGD","LU0965509283.SGD","SG9999014559.SGD","BK1161","LU1983299246.USD","IE00B4R5TH58.HKD","09926","SG9999013999.USD","LU2488822045.USD","MRK","LU1585245621.USD","LU1794554557.SGD","LU1162221912.USD","LU2023250843.SGD","SG9999001440.SGD","SG9999002224.SGD","LU2361044865.SGD","LU0320765489.SGD","LU1066053197.SGD","LU1941712348.USD","LU1066051225.USD","LU0203345920.USD","IE00BSNM7G36.USD","LU0417516571.SGD","LU1941712264.USD","LU0006306889.USD","LU2468319806.SGD","LU0965509010.AUD","LU0208291251.USD","SG9999015341.SGD","LU1934455277.USD","IE00BLSP4239.USD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU1430594728.SGD","LU0320765646.SGD","LU1929549753.HKD","SG9999001176.SGD","LU2106854487.HKD","LU0106261372.USD","LU0203347892.USD","LU0861579265.USD","LU2112291526.USD","LU1037948897.HKD"],"gpt_icon":0},{"id":"2517910639","title":"国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910639","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910639?lang=zh_cn&edition=full","pubTime":"2025-03-07 17:00","pubTimestamp":1741338046,"startTime":"0","endTime":"0","summary":"【国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了】去年9月8日,国产企业康方生物(09926.HK)双抗药物依沃西,从疗效上战胜了全球药王帕博利珠单抗(即“K药”)的消息传开后,引发资本市场沸腾。时至今日,康方生物港股股价涨幅在50%左右。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503073339808148.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503073339808148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK4534","IE00B1BXHZ80.USD","BK4585","SG9999002224.SGD","LU0348784397.USD","LU0211331839.USD","LU0985320562.USD","LU1989771016.USD","LU1794554557.SGD","LU1066053197.SGD","LU2324357040.USD","LU1116320737.USD","SG9999014575.USD","SGXZ57979304.SGD","IE000M9KFDE8.USD","LU0320765646.SGD","BK4007","LU1989772840.SGD","IE00BBT3K403.USD","LU2488822045.USD","LU1720050803.USD","LU1061106388.HKD","LU0070302665.USD","LU0238689110.USD","BK4550","SG9999002232.USD","LU1699723380.USD","LU1941712264.USD","09926","IE00BJJMRZ35.SGD","LU0203345920.USD","LU2361044949.HKD","MRK","PFS","IE00BJT1NW94.SGD","LU1066051498.USD","LU2089984988.USD","LU2361044865.SGD","SG9999001176.SGD","LU1057294990.SGD","LU0265550946.USD","LU1093756325.SGD","LU1023059063.AUD","LU0320765489.SGD","LU0265550359.USD","LU0965509010.AUD","LU0208291251.USD","LU0106261372.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2517150640","title":"金十数据整理:每日美股市场要闻速递(3月6日 周四)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150640","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517150640?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:50","pubTimestamp":1741269018,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AAPL","NVD","IE00BZ1G4Q59.USD","NVD3.UK","LOGI","09939","QCOM","AMZN","NVDA","SNVD.UK","BABA","159938","DDL","EWT","NVDD","TSLL","MU","META","HPQ","IE0009356076.USD","MRK","NVDY","TWmain","MSFT","3NVD.UK","159646","TSYW.SI","MACW.SI","NVDX","RTX","89618","MRNA","TSLA","TSM","2NVD.UK","03145","09988","IBM","NVD2.UK","NVDS","NVDU","XMAG","09618","JD","UMC","NVDS.UK","NVDL","NVIW.SI","INTC","GOOG"],"gpt_icon":1},{"id":"2517418031","title":"首个肿瘤疫苗有望在2027年推出,用于治疗这种癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=2517418031","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517418031?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:03","pubTimestamp":1741248208,"startTime":"0","endTime":"0","summary":"当地时间3月5日,美国疫苗厂商Moderna在投资者会议上表示,该公司有望于2027年推出首个肿瘤疫苗。当天收盘,Moderna股价大涨近16%。Moderna正在与默沙东共同开发一款个性化的肿瘤疫苗,并已对严重的皮肤癌(黑色素瘤)患者进行后期临床试验。Moderna公司总裁StephenHoge在周三的投资者会议上表示,首款肿瘤疫苗可能有机会为公司带来“相当大的收入”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063338506797.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338506797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE000M9KFDE8.USD","LU0234572021.USD","LU0965509101.SGD","LU0965509010.AUD","SG9999001440.SGD","IE00BLSP4452.SGD","SG9999014567.USD","IE0009355771.USD","LU1162221912.USD","LU0058720904.USD","BK4559","LU1699723380.USD","IE00BLSP4239.USD","LU2023250504.SGD","LU0070302665.USD","LU0985320562.USD","LU1069347547.HKD","LU1571399168.USD","IE00B1BXHZ80.USD","IE0002141913.USD","LU1983299246.USD","LU0211331839.USD","SG9999002224.SGD","SG9999001176.USD","LU0965509283.SGD","LU1291159041.SGD","LU1934455277.USD","BK4533","BK4550","LU1066051811.HKD","LU2361045086.USD","LU1917777945.USD","LU1989772923.USD","LU0203345920.USD","LU1989772840.SGD","LU2023250843.SGD","BK4516","LU1585245621.USD","MRK","LU0289739699.SGD","LU1037948541.HKD","LU0106261372.USD","LU2112291526.USD","LU0266013472.USD","LU0265550359.USD","LU2361044949.HKD","SGXZ57979304.SGD","BK4585","BK4588","LU0265550946.USD"],"gpt_icon":0},{"id":"2517187515","title":"首个肿瘤疫苗有望在2027年推出 用于治疗皮肤癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2517187515","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517187515?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:01","pubTimestamp":1741248092,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["IE00BFTCPJ56.SGD","SG9999014542.SGD","LU1941712264.USD","03347","BK4516","IE00B4R5TH58.HKD","LU2361044865.SGD","LU0238689110.USD","LU2361044949.HKD","LU0203347892.USD","LU1037948897.HKD","LU1066051811.HKD","LU1291159041.SGD","SG9999015341.SGD","LU1116320737.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0203345920.USD","LU1934455277.USD","SG9999014567.USD","SG9999014575.USD","LU1989772840.SGD","IE0002141913.USD","LU1934455194.USD","LU1023059063.AUD","LU1061106388.HKD","BK4585","LU0208291251.USD","LU1066053197.SGD","LU1917777945.USD","LU2106854487.HKD","SG9999015358.SGD","LU1989771016.USD","LU2324357040.USD","SGXZ57979304.SGD","LU1929549753.HKD","BK4559","IE00B2B36J28.USD","BK4007","LU0106261372.USD","LU0265550946.USD","LU0266013472.USD","LU0965509101.SGD","BK4534","LU1093756168.USD","MRK","SG9999001440.SGD","SG9999002232.USD","SG9999001176.USD","159646"],"gpt_icon":0},{"id":"2517290589","title":"【Moderna预计2027年推出与默沙东共同开发的皮肤癌症疫苗】Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517290589","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517290589?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:54","pubTimestamp":1741229648,"startTime":"0","endTime":"0","summary":"Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06105448555932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2361044865.SGD","LU2106854487.HKD","LU1989772840.SGD","LU2461242641.AUD","MRK","LU1989771016.USD","LU1116320901.HKD","LU1069347547.HKD","IE00B1BXHZ80.USD","SG9999014575.USD","LU1699723380.USD","SG9999014542.SGD","LU1057294990.SGD","LU1116320737.USD","LU1974910355.USD","IE00B2B36J28.USD","LU1430594728.SGD","SG9999001440.SGD","SG9999014567.USD","SG9999015358.SGD","SG9999014559.SGD","IE00BN8TJ469.HKD","LU1093756325.SGD","BK4585","SG9999002232.USD","IE0002141913.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU0965508806.USD","LU1571399168.USD","LU1037948541.HKD","LU1061106388.HKD","LU1941712264.USD","LU1989772923.USD","SG9999002224.SGD","BK4533","SG9999001176.USD","LU0106261372.USD","LU2324357040.USD","LU2361045086.USD","BK4516","LU1585245621.USD","IE00BBT3K403.USD","159646","LU0122379950.USD","IE00BLSP4239.USD","LU0238689110.USD","LU1023059063.AUD","LU1983299246.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2517469974","title":"Moderna(MRNA.US)携手默沙东(MRK.US)冲刺2027 一款重磅皮肤癌疫苗进入倒计时","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469974","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517469974?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:11","pubTimestamp":1741223492,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,mRNA疫苗领域领军者Moderna 计划在2027年获得其与美国医药巨头默沙东合作开发的个性化皮肤癌疫苗的正式市场批准,这是一种针对皮肤癌的个性化精准疫苗,Moderna一名高管在美东时间周三的一场投资者活动上宣布。在周三举行的TD Cowen美国医疗健康大会上,Moderna总裁斯蒂芬·霍格指出,旨在测试该公司皮肤癌疫苗V940针对黑色素瘤疗效的后期阶段试验已完成全部受试者入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","LU2361044865.SGD","LU1037948541.HKD","BK4548","LU2106854487.HKD","159646","LU1974910355.USD","LU0203347892.USD","LU0265550946.USD","LU1035773651.USD","LU0965509010.AUD","LU1934455277.USD","LU1430594728.SGD","IE00B1BXHZ80.USD","MRNA","SG9999001176.USD","LU1983299246.USD","IE00BBT3K403.USD","LU1066051811.HKD","LU0965508806.USD","BK4588","SG9999001176.SGD","LU1116320901.HKD","BK4501","LU2112291526.USD","MRK","LU0203345920.USD","SG9999014575.USD","SG9999013999.USD","LU2361044949.HKD","LU0320765646.SGD","SG9999014559.SGD","IE0009355771.USD","LU1934455863.HKD","LU1929549753.HKD","LU1571399168.USD","SG9999014542.SGD","LU0208291251.USD","LU1069347547.HKD","LU2461242641.AUD","LU0965509101.SGD","IE00BN8TJ469.HKD","LU2324357040.USD","BK4568","LU0238689110.USD","LU0106261372.USD","LU0965509283.SGD","LU1941712348.USD","LU2023250504.SGD","LU1093756168.USD"],"gpt_icon":1},{"id":"2517912810","title":"传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912810","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517912810?lang=zh_cn&edition=full","pubTime":"2025-03-05 21:41","pubTimestamp":1741182111,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据报道,奥洛兹美医疗 与默沙东之间正在酝酿一场新的专利纠纷,争议的焦点是抗癌重磅药物Keytruda的注射版。知情人士透露,奥洛兹美医疗认为默沙东侵犯了其专利,应该签订许可协议才能销售注射用Keytruda。Keytruda几乎贡献了默沙东一半的总营收。默沙东去年表示,其注射版Keytruda在关键的3期试验中达到了主要目标。据报道,奥洛兹美医疗将在周三的投资者活动上讨论注射版Keytruda专利问题。截至发稿,默沙东盘前跌0.54%,奥洛兹美医疗涨0.81%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1093756325.SGD","LU2089984988.USD","LU1116320737.USD","LU0122379950.USD","BK4139","LU1066053197.SGD","IE00BBT3K403.USD","LU1989772923.USD","LU1035773651.USD","LU1934455277.USD","LU1023059063.AUD","SG9999015358.SGD","LU0265550359.USD","IE00BSNM7G36.USD","LU1066051225.USD","LU1066051811.HKD","LU1291159041.SGD","LU1974910355.USD","SG9999013999.USD","MRK","LU0053671581.USD","LU1571399168.USD","LU0238689110.USD","LU1585245621.USD","SG9999015341.SGD","LU1699723380.USD","LU0203347892.USD","HALO","LU0965509010.AUD","LU2023250843.SGD","SG9999002224.SGD","BK4007","LU1066051498.USD","LU1917777945.USD","LU0965509283.SGD","BK4534","LU1093756168.USD","LU0965509101.SGD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU1983299246.USD","LU1989772840.SGD","SG9999002232.USD","LU1162221912.USD","IE0002141913.USD","LU2106854487.HKD","IE00B1BXHZ80.USD","LU1934455194.USD","SG9999014575.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.1765},{"period":"3month","weight":-0.2034},{"period":"6month","weight":-0.2824},{"period":"1year","weight":-0.3778},{"period":"ytd","weight":-0.2159}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.009524},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.001865},{"month":3,"riseRate":0.622222,"avgChangeRate":-0.002869},{"month":4,"riseRate":0.608696,"avgChangeRate":0.015343},{"month":5,"riseRate":0.644444,"avgChangeRate":0.018719},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.028573},{"month":12,"riseRate":0.6,"avgChangeRate":0.013993}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}